» Articles » PMID: 31887849

Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Ace Card to Address Autoimmune Diseases

Overview
Date 2019 Dec 31
PMID 31887849
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

With the development of novel treatments for autoimmune disorders, it has become a popular research focus which mesenchymal stem cells (MSCs) have the capacity to counteract with autoimmune diseases progression. One of the underlying mechanisms behind their activities is the release of extracellular vesicles especially exosomes. MSC-derived exosomes are hypoimmunogenic nanocarriers which contain numerous immunoregulatory factors and similar to other exosomes, are able to pass through boundaries like the blood-brain barrier (BBB). Accumulating evidence provided by animal studies has demonstrated that MSC-derived exosomes, as a novel therapy, can re-induce self-tolerance, without subsequent complications reported for other treatments. Therefore, therapeutic applications of MSC-derived exosomes are contributing to core advances in the field of autoimmune diseases. Here, we briefly describe the biological characteristics of MSC-derived exosomes and review the experimentally verified outcomes for autoimmune disease therapy purposes.

Citing Articles

Recent advances in adipose-derived mesenchymal stem cell-derived exosomes for regulating macrophage polarization.

Dong Z, Fu Y, Cai Z, Dai H, He Y Front Immunol. 2025; 16:1525466.

PMID: 39963133 PMC: 11830602. DOI: 10.3389/fimmu.2025.1525466.


Review of mesenchymal stem cell-derived exosomes and their potential therapeutic roles in treating rheumatoid arthritis.

Aghajani S, Maboudi S, Seyhoun I, Nia R, Shabestari A, Sharif S Mol Biol Rep. 2025; 52(1):229.

PMID: 39948229 DOI: 10.1007/s11033-025-10290-z.


Bone marrow mesenchymal stem cell-derived extracellular vesicle infusion for amyotrophic lateral sclerosis.

Crose J, Crose A, Ransom J, Lightner A Neurodegener Dis Manag. 2024; 14(3-4):111-117.

PMID: 39352708 PMC: 11457643. DOI: 10.1080/17582024.2024.2344396.


Cellular In Vitro Responses Induced by Human Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles Obtained from Suspension Culture.

Souza I, Suzukawa A, Josino R, Marcon B, Robert A, Shigunov P Int J Mol Sci. 2024; 25(14).

PMID: 39062847 PMC: 11277484. DOI: 10.3390/ijms25147605.


Proteomic analysis and functional validation reveal distinct therapeutic capabilities related to priming of mesenchymal stromal/stem cells with IFN-γ and hypoxia: potential implications for their clinical use.

Calligaris M, Zito G, Busa R, Bulati M, Iannolo G, Gallo A Front Cell Dev Biol. 2024; 12:1385712.

PMID: 38882056 PMC: 11179434. DOI: 10.3389/fcell.2024.1385712.


References
1.
Sargent A, Shano G, Karl M, Garrison E, Miller C, Miller R . Transcriptional Profiling of Mesenchymal Stem Cells Identifies Distinct Neuroimmune Pathways Altered by CNS Disease. Int J Stem Cells. 2018; 11(1):48-60. PMC: 5984058. DOI: 10.15283/ijsc17062. View

2.
Choi H, Lee D . Illuminating the physiology of extracellular vesicles. Stem Cell Res Ther. 2016; 7(1):55. PMC: 4833943. DOI: 10.1186/s13287-016-0316-1. View

3.
Crisan M, Corselli M, Chen C, Peault B . Multilineage stem cells in the adult: a perivascular legacy?. Organogenesis. 2011; 7(2):101-4. PMC: 3142446. DOI: 10.4161/org.7.2.16150. View

4.
Pham H, Tonai R, Wu M, Birtolo C, Chen M . CD73, CD90, CD105 and Cadherin-11 RT-PCR Screening for Mesenchymal Stem Cells from Cryopreserved Human Cord Tissue. Int J Stem Cells. 2018; 11(1):26-38. PMC: 5984056. DOI: 10.15283/ijsc17015. View

5.
Malmstrom V, Catrina A, Klareskog L . The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting. Nat Rev Immunol. 2016; 17(1):60-75. DOI: 10.1038/nri.2016.124. View